Advances in Targeted Delivery of Doxorubicin for Cancer Chemotherapy
Doxorubicin (DOX) is one of the most powerful chemotherapy drugs used to treat different kinds of cancer. However, its usage has been limited by typical side effects and drug resistance, particularly cardiotoxicity. According to studies, a more effective and promising method is to conjugate it or en...
Saved in:
| Main Authors: | Wenhui Xia, Martin W. King |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Bioengineering |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2306-5354/12/4/430 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
by: Fatih Ciftci, et al.
Published: (2025-01-01) -
Harnessing nature: plant-derived nanocarriers for targeted drug delivery in cancer therapy
by: Esther Ugo Alum, et al.
Published: (2025-08-01) -
Progress in the Application of Novel Nanomaterials in Targeted Therapy for Liver Cancer
by: Wei X, et al.
Published: (2025-03-01) -
Aspirin in Cancer Therapy: Pharmacology and Nanotechnology Advances
by: Laila UE, et al.
Published: (2025-02-01) -
Peptide-Functionalized Nanomedicine: Advancements in Drug Delivery, Diagnostics, and Biomedical Applications
by: Hossein Omidian, et al.
Published: (2025-03-01)